Accessibility Menu
Caliber Imaging & Diagnostics logo

Caliber Imaging & Diagnostics(OTC) LCDX

Market Cap$5.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-100%
5 Year-100%
1 Year+500%
1 Month+0%
$0.00
+100.00%
+0.00Today
Caliber Imaging & Diagnostics last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-05
Caliber Imaging & Diagnostics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-29
1 month+0%USD 0.002026-07-06
3 month-25%USD 0.002026-04-29
Year to date+0%USD 0.002025-12-31
1 year+500%USD 0.002025-07-29
3 year+50%USD 0.002023-08-03
5 year-99.79%USD 0.292021-08-06
Since inception-99.97%USD 2.002012-04-10

Caliber Imaging & Diagnostics Financials at a Glance

Market Cap

$5.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.14M

Net Income (TTM)

-$6.25M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-51.55 (Low)

Price

$0.00

Volume

800

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

N/A

LCDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm specializing in advanced imaging solutions that visualize tissue at a cellular resolution. The company develops and markets innovative products designed to enhance diagnostic capabilities in medical practices.

Products and Services
  • VivaScope 1500: A confocal imaging system for detailed tissue imaging
  • VivaScope 3000: A handheld confocal microscope for dermatological applications
  • VivaScan software: Streamlines patient scheduling and image reporting
Growth Outlook
  • Increasing demand for non-invasive diagnostic tools in dermatology
  • Expansion into telepathology with the VivaNet system
  • Potential partnerships with healthcare providers to enhance product reach
Financial Highlights
  • Recent quarterly revenue of 858,138, showing growth potential
  • Trailing twelve months gross profit margin at 19.57%, indicating operational efficiency
  • Current ratio of 0.31, reflecting liquidity challenges but potential for improvement
Caliber Imaging & Diagnostics, Inc. operates in the medical devices sector, focusing on innovative imaging technologies that cater to healthcare professionals. The company's flagship products, such as the VivaScope series, are designed to provide high-resolution imaging, which is crucial for accurate diagnostics. The growth outlook appears promising, driven by the increasing need for non-invasive diagnostic solutions and the potential for strategic partnerships in the healthcare sector. Financially, the company reported a recent quarterly revenue of 858,138, which reflects its ability to generate income despite challenges. The gross profit margin of 19.57% over the trailing twelve months indicates a level of operational efficiency that could be leveraged for future growth. However, the current ratio of 0.31 suggests liquidity challenges that may need to be addressed to ensure sustainable operations. Overall, Caliber Imaging & Diagnostics, Inc. presents an intriguing opportunity for investors interested in the medical technology space.
AI Generated • Aug 4, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Andover, MA 01810, US

LCDX Financials

Key Financial Metrics (TTM)

Gross Margin

19.57%

Operating Margin

-145.24%

Net Income Margin

-163.99%

Return on Equity

54.25%

Return on Capital

N/A

Return on Assets

-227.57%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.51M

Volume

800

Avg. Volume

1.26K

Financials (TTM)

Gross Profit

$486.00K

Operating Income

-$5.50M

EBITDA

-$5.25M

Operating Cash Flow

-$4.76M

Capital Expenditure

-$194.26K

Free Cash Flow

-$4.94M

Cash & ST Invst.

$229.54K

Total Debt

$5.12M

Caliber Imaging & Diagnostics Performance Analysis

Caliber Imaging & Diagnostics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22013-06-30-51.3%
Q32013-09-3034.1%
Q42013-12-3155.4%
Q12014-03-31-20.2%
Caliber Imaging & Diagnostics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22013-06-30-15.4%
Q32013-09-30-46.7%
Q42013-12-3129.6%
Q12014-03-31-42.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2014YOY CHG

Revenue

$858.14K

-18.9%

Gross Profit

$142.36K

-54.1%

Gross Margin

16.59%

N/A

Market Cap

$5.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$182.14

N/A

Employees

28

N/A

Net Income

-$1.82M

-73.2%

EBITDA

-$1.59M

-75.1%

Quarterly Fundamentals

Name
Q1 2014YOY CHG

Total Cash

$229.54K

-31.1%

Total Debt

$5.12M

+1297.7%

Accounts Receivable

$390.86K

+16.5%

Inventory

$1.01M

+33.5%

Long Term Debt

$0.00

N/A

Short Term Debt

$5.12M

+1297.7%

Return on Assets

-2.28%

N/A

Return on Invested Capital

96.99%

N/A

Free Cash Flow

-$656.97K

-13.2%

Operating Cash Flow

-$485.21K

+14.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CECBFSaltbae Capital Corp.
$0.00+0.00%
TPTWTPT Global Tech, Inc.
$0.00+0.00%
OXBROxbridge Re Holdings Limited
$1.30+7.44%
NNOXNano-X Imaging Ltd.
$0.99-3.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About LCDX

What is the current price of Caliber Imaging & Diagnostics?

Caliber Imaging & Diagnostics is trading at $0.00 per share.

What is the 52-week range for Caliber Imaging & Diagnostics?

Over the past 52 weeks, Caliber Imaging & Diagnostics has traded between $0.00 and $0.05.

How much debt does Caliber Imaging & Diagnostics have?

Caliber Imaging & Diagnostics total debt is unavailable.

How much cash does Caliber Imaging & Diagnostics have on hand?

Caliber Imaging & Diagnostics does not have cash on hand data available.

What is Caliber Imaging & Diagnostics’s dividend yield?

Caliber Imaging & Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.